Guidance for defining outcomes in clinical trials
Authors:
- Xiangji YingXYXiangji Ying
- Joanne E. McKenzieJMJoanne E. McKenzie
- Matthew J. PageMPMatthew J. Page
- Kiran NinanKNKiran Ninan
- Jean-Pierre ObersteJOJean-Pierre Oberste
- Colby J. VorlandCVColby J. Vorland
- Andrew W. BrownABAndrew W. Brown
- Riaz QureshiRQRiaz Qureshi
- Nicholas J. DeVitoNDNicholas J. DeVito
- Ian J. SaldanhaISIan J. Saldanha
- Martin OffringaMOMartin Offringa
Open Access
- 21 October 2026
- journal article
- guideline
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (10) , e1005275
Abstract
Background: Defining outcomes completely before conducting clinical trials helps to mitigate concerns about reporting biases; however, there is limited guidance to help investigators define outcomes completely. Methods: Building on a previous framework, we developed guidance for defining trial outcomes completely and consistently. We reviewed literature, developed preliminary guidance, and refined guidance iteratively through pilot testing. We randomly selected 225 randomized controlled trials (RCTs) from ClinicalTrials.gov, which evaluated 3,424 outcomes. Two raters followed a structured approach to define each outcome. When raters encountered outcomes they could not define, we refined our guidance. We continued this process until no further changes were needed. We finalized the guidance through multiple drafts and discussions among authors. Findings: In clinical trials, a completely defined outcome includes six elements: outcome domain, specific measurement, specific metric, cutoff (if applicable), variable type, and time point. We developed guidance for naming specific measurements for both subjective and objective outcomes. We expanded on prior work by describing more comprehensive categories for specific metrics. To be consistent with the estimand framework, we replaced “method of aggregation” with two distinct elements that describe values in individuals (rather than summary measures): “variable type” and “cutoff.” We further defined “cutoff” with three sub-elements, and we defined “variable type” as whether the value for each individual is continuous or categorical. Conclusions: Trialists and sponsors could use this framework and guidance to define outcomes in trial registrations, protocols, and results reports. When all six elements are defined, readers can better determine whether reported outcomes were prespecified and whether different trials assessed the same outcomes.Keywords
Funding Information
- U.S. National Library of Medicine (R01LM014079)
- University of North Carolina at Chapel Hill (UNC Provost’s AI Acceleration program cloud resource grant)
This publication has 30 references indexed in Scilit:
- Guidelines for Reporting Outcomes in Trial ProtocolsJAMA, 2022
- Guidelines for Reporting Outcomes in Trial ReportsJAMA, 2022
- A taxonomy has been developed for outcomes in medical research to help improve knowledge discoveryJournal of Clinical Epidemiology, 2018
- Journal article reporting standards for quantitative research in psychology: The APA Publications and Communications Board task force report.American Psychologist, 2018
- Practical guidance for using multiple data sources in systematic reviews and meta‐analyses (with examples from the MUDS study)Research Synthesis Methods, 2017
- Update on Trial Registration 11 Years after the ICMJE Policy Was EstablishedNew England Journal of Medicine, 2017
- Toward a New Era of Trust and Transparency in Clinical TrialsJAMA, 2016
- The ClinicalTrials.gov Results Database — Update and Key IssuesNew England Journal of Medicine, 2011
- Clinical Trial Registration: A Statement from the International Committee of Medical Journal EditorsNew England Journal of Medicine, 2004
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990